KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Inventory (2017 - 2025)

Historic Inventory for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $9.1 billion.

  • Takeda Pharmaceutical's Inventory rose 1150.87% to $9.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 billion, marking a year-over-year increase of 1150.87%. This contributed to the annual value of $8.0 billion for FY2025, which is 474.01% down from last year.
  • As of Q4 2025, Takeda Pharmaceutical's Inventory stood at $9.1 billion, which was up 1150.87% from $8.8 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Inventory ranged from a high of $9.1 billion in Q4 2025 and a low of $6.6 billion during Q4 2022
  • Over the past 5 years, Takeda Pharmaceutical's median Inventory value was $7.9 billion (recorded in 2023), while the average stood at $7.7 billion.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Inventory tumbled by 803.93% in 2022, and later surged by 2055.67% in 2023.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Inventory stood at $7.1 billion in 2021, then fell by 8.04% to $6.6 billion in 2022, then rose by 20.56% to $7.9 billion in 2023, then grew by 3.61% to $8.2 billion in 2024, then rose by 11.51% to $9.1 billion in 2025.
  • Its Inventory was $9.1 billion in Q4 2025, compared to $8.8 billion in Q3 2025 and $8.6 billion in Q2 2025.